Restoration of Complement-Enhanced Neutralization of Vaccinia Virus Virions by Novel Monoclonal Antibodies Raised against the Vaccinia Virus Complement Control Protein
- 1 August 2003
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (15) , 8256-62
- https://doi.org/10.1128/jvi.77.15.8256-8262.2003
Abstract
The vaccinia virus complement control protein (VCP) is secreted by infected cells and has been shown to inhibit complement activation through interactions with C3b/C4b. It contains four short consensus repeat (SCR) domains. It has been suggested that all four SCRs are required for VCP's activity. To elucidate which SCR domains are involved in abolishing complement-enhanced neutralization of vaccinia virus virions, we generated and characterized a panel of mouse monoclonal antibodies (MAbs) raised against VCP. Ten MAbs were isolated and all recognized VCP on Western blots under reducing conditions as well as native-bound VCP in a sandwich enzyme-linked immunosorbent assay. Three of the 10 MAbs (2E5, 3D1, and 3F11) inhibited VCP's abolition of complement-enhanced neutralization of vaccinia virus virions. These MAbs blocked the interaction of VCP with C3b/C4b. The seven remaining MAbs did not alter VCP function in the complement neutralization assay and recognized VCP bound to C3b/C4b. To understand MAb specificity and mode of interaction with VCP, we mapped the MAb binding regions on VCP. The seven nonblocking MAbs all bound to the first SCR of VCP. One of the blocking MAbs recognized SCR 2 while the other two recognized either SCR 4 or the junction between SCRs 3 and 4, indicating that structural elements involved in the interaction of VCP with C3b/C4b are located within SCR domains 2 and 3 and 4. These anti-VCP MAbs may have clinical significance as therapeutic inhibitors of VCP's complement control activity and may also offer a novel approach to managing vaccinia virus vaccine complications that occur from smallpox vaccination.Keywords
This publication has 25 references indexed in Scilit:
- Developing New Smallpox VaccinesEmerging Infectious Diseases, 2001
- Solution structure and dynamics of the central CCP module pair of a poxvirus complement control proteinJournal of Molecular Biology, 2001
- RETRACTED: Crystal Structure of a Complement Control Protein that Regulates Both Pathways of Complement Activation and Binds Heparan Sulfate ProteoglycansCell, 2001
- Interaction of vaccinia virus complement control protein with human complement proteins: Factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathwayMolecular Immunology, 1998
- Regulatory Proteins of ComplementPublished by Taylor & Francis ,1998
- Analysis of the Complete Genome of Smallpox Variola Major Virus Strain Bangladesh-1975Virology, 1994
- Potential virulence determinants in terminal regions of variola smallpox virus genomeNature, 1993
- Regulation of Complement Activity by Vaccinia Virus Complement-Control ProteinThe Journal of Infectious Diseases, 1992
- Inhibition of the Complement Cascade by the Major Secretory Protein of Vaccinia VirusScience, 1990
- Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteinsNature, 1988